<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and related syndromes exhibit a deadly triad of dyslipoproteinemia, which leads to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>; <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, which causes microvascular disease; and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>These features share a common, but unexplained, origin-namely, pathway-selective <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and responsiveness </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we undertook a comprehensive characterization of pathway-selective <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and responsiveness in liver and hepatocytes by examining 18 downstream targets of the insulin receptor, surveying the AKT, ERK, and <z:chebi fb="0" ids="13392">NAD(P)H</z:chebi> oxidase 4 pathways </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Injection of insulin into hyperphagic, <z:mp ids='MP_0001261'>obese</z:mp> type 2 diabetic db/db mice failed to inactivate hepatic protein tyrosine phosphatase gene family members, a crucial action of <z:chebi fb="0" ids="13392">NAD(P)H</z:chebi> oxidase 4 previously thought to be required for <z:hpo ids='HP_0000001'>all</z:hpo> signaling through AKT and ERK </plain></SENT>
<SENT sid="4" pm="."><plain>Insulin-stimulated type 2 diabetic livers unexpectedly produced an unusual form of AKT that was phosphorylated at Thr308 (pT308), with only weak insulin-stimulated phosphorylation at Ser473 </plain></SENT>
<SENT sid="5" pm="."><plain>Remarkably, knockdown or inhibition of <z:chebi fb="0" ids="13392">NAD(P)H</z:chebi> oxidase 4 in cultured hepatocytes recapitulated the entire complicated pattern of pathway-selective <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and responsiveness seen in vivo-namely, monophosphorylated pT308-AKT, impaired insulin-stimulated pathways for lowering plasma <z:chebi fb="23" ids="18059">lipids</z:chebi> and <z:chebi fb="105" ids="17234">glucose</z:chebi>, but continued lipogenic pathways and robust ERK activation </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Functional disturbance of a single molecule, <z:chebi fb="0" ids="13392">NAD(P)H</z:chebi> oxidase 4, is sufficient to induce the key harmful features of deranged insulin signaling in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:hpo ids='HP_0001513'>obesity</z:hpo>, and other conditions associated with <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> and pathway-selective <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and responsiveness </plain></SENT>
</text></document>